Results 1 to 10 of about 4,616 (67)
Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Retinal Disorders
Pharmaceuticals, 2023 Vascular endothelial growth factors (VEGFs) are key mediator of retinal and choroidal neovascularization as well as retinal vascular leakage leading to macular edema.
Abraham Hang +4 more
doaj +3 more sources
Anti-cancer effects of F16: A novel vascular endothelial growth factor receptor–specific inhibitor
Tumor Biology, 2017 Vascular endothelial growth factor receptor-2 is a dynamic target for therapeutic intervention in various types of cancers. This study was aimed to explore the anti-angiogenic activity of a novel vascular endothelial growth factor receptor–specific ...
Appu Rathinavelu +3 more
doaj +2 more sources
Journal of Medical Case Reports, 2021 Background Intravitreal injections of anti-vascular endothelial growth factor are commonly used to treat macular diseases, including diabetic macular edema.
Miwako Yoshimoto +3 more
doaj +1 more source
Newer anti-vascular endothelial growth factor agents
TNOA Journal of Ophthalmic Science and Research, 2020 Ocular angiogenesis is a major cause of ocular morbidity worldwide. Vascular endothelial growth factor (VEGF) is a critical regulator of angiogenesis and vascular permeability with diverse roles both during the development and adulthood. This is believed
Priya Rasipuram Chandrasekaran
doaj +1 more source
Anti Vascular Endothelial Growth Factor Agents in Corneal Neovascularization
Delhi Journal of Ophthalmology, 2011 Corneal neovascularisation is a potentially blinding condition, an established risk factor for rejection and results in loss of immune privilege. It may occur as a normal physiologic healing response to various stimuli or as an inappropriate local tissue
Srivatsa Sehra, Reetika
doaj +1 more source
International Breastfeeding Journal, 2022 Background Ranibizumab is one of intravitreal anti-vascular endothelial growth factor agents. It is applied in the treatments of choroidal neovascularization, age-related macular degeneration, diabetic macular edema, and macular edema secondary to ...
Ying Huang +4 more
doaj +1 more source
Acta Pharmaceutica, 2022 Statins have shown anti-inflammatory pleiotropic effects in subjects with/at risk of cardiovascular disease. The aim of this study was to evaluate the inflammatory/immunomodulatory properties of rosuvastatin in subjects at low-to-moderate cardiovascular ...
VAVLUKIS ANA +6 more
doaj +1 more source
Newly Identified Peptide, Peptide Lv, Promotes Pathological Angiogenesis
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2019 Background We recently discovered a small endogenous peptide, peptide Lv, with the ability to activate vascular endothelial growth factor receptor 2 and its downstream signaling.
Liheng Shi +12 more
doaj +1 more source
IJU Case Reports, 2023 Introduction Renal cell carcinoma with TFEB amplification is rare and reportedly aggressive. We herein report a case of renal cell carcinoma with TFEB translocation and amplification in which long‐term control was achieved by multimodal therapy including
Hajime Takamori +5 more
doaj +1 more source
Hypoxia-induced reactive oxygen species cause chromosomal abnormalities in endothelial cells in the tumor microenvironment. [PDF]
PLoS ONE, 2013 There is much evidence that hypoxia in the tumor microenvironment enhances tumor progression. In an earlier study, we reported abnormal phenotypes of tumor-associated endothelial cells such as those resistant to chemotherapy and chromosomal instability ...
Miyako Kondoh +8 more
doaj +1 more source